Riva-Senna 8.6 mg
Natural health product licensed in Canada
- Other names
- Riva-Senna, Sennosides 8.6 mg
- Licence holder
- Laboratoire Riva Inc.
- NPN or DIN-HM
- 80079605
- Status
- Inactive licence
- Licence date
- 22 August 2017
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sennoside A&B Source : Sennoside de calcium | 8.6 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Talc, Poly(éthylène glycol), Dichlorométhane, Croscarmellose de sodium, Stéarate de magnésium, Alcool isopropylique, Phosphate dicalcique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes (enceintes et/ou allaitantes) | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 day ; maximum: 2 days |
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 4 Comprimé | minimum: 1 day ; maximum: 2 days |
| Enfants | minimum: 9 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
For relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea.
Source
Official Health Canada record, licence 80079605
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.